241 related articles for article (PubMed ID: 27216817)
1. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
2. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
Ramesh V; Ganesan K
Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma associated lipid metabolism reprogramming.
Skill NJ; Scott RE; Wu J; Maluccio MA
J Surg Res; 2011 Jul; 169(1):51-6. PubMed ID: 19932908
[TBL] [Abstract][Full Text] [Related]
4. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
5. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
[TBL] [Abstract][Full Text] [Related]
7. An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA MALAT1 in the Regulation of Lipid Metabolism.
Wang H; Zhang Y; Guan X; Li X; Zhao Z; Gao Y; Zhang X; Chen R
Mol Cell Proteomics; 2021; 20():100141. PubMed ID: 34478876
[TBL] [Abstract][Full Text] [Related]
8. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.
Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; SantamarÃa E; Corrales FJ
Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899
[TBL] [Abstract][Full Text] [Related]
9. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.
Bidkhori G; Benfeitas R; Klevstig M; Zhang C; Nielsen J; Uhlen M; Boren J; Mardinoglu A
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11874-E11883. PubMed ID: 30482855
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
[TBL] [Abstract][Full Text] [Related]
11. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
12. Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis.
Benfeitas R; Bidkhori G; Mukhopadhyay B; Klevstig M; Arif M; Zhang C; Lee S; Cinar R; Nielsen J; Uhlen M; Boren J; Kunos G; Mardinoglu A
EBioMedicine; 2019 Feb; 40():471-487. PubMed ID: 30606699
[TBL] [Abstract][Full Text] [Related]
13. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
14. Functional and topological properties in hepatocellular carcinoma transcriptome.
Drozdov I; Bornschein J; Wex T; Valeyev NV; Tsoka S; Malfertheiner P
PLoS One; 2012; 7(4):e35510. PubMed ID: 22539975
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
16. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.
Teng CF; Hsieh WC; Yang CW; Su HM; Tsai TF; Sung WC; Huang W; Su IJ
Mol Carcinog; 2016 Jan; 55(1):105-14. PubMed ID: 25594851
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs: critical players in hepatocellular carcinoma.
Sun J; Bie B; Zhang S; Yang J; Li Z
Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
20. Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
Ramesh V; Ganesan K
Int J Cancer; 2016 Oct; 139(7):1586-97. PubMed ID: 27194100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
